Where does Niconovum USA, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Niconovum USA, Inc. ranks #26,974 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Niconovum USA, Inc. hold?

Niconovum USA, Inc. holds 10 US utility patents granted between 2016 and 2023, spanning 9 technology areas.

What is Niconovum USA, Inc.'s Innovation Score?

Niconovum USA, Inc. has an Innovation Score of 34.8 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Niconovum USA, Inc.'s patent grant rate increasing or decreasing?

Niconovum USA, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Niconovum USA, Inc.'s patents?

Niconovum USA, Inc.'s patents average 21.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Niconovum USA, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Niconovum USA, Inc.

Q: What technology areas does Niconovum USA, Inc. focus on?

Niconovum USA, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 9 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Niconovum ranks #26,974 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 9 technology areas.

#26,974
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.8/100): 21.0
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26974 · US Corporation #26,974 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,974/49,997
PHOTO-FINISH Nextern
CPC-NARROW A61P · 9 areas
INNOV-THIN 34.8/100
CLAIMS-DENSE 21.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nextern Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Niconovum USA · this assignee

35
3D Lighting… · lowest

7

What this shows Niconovum's Innovation Score is 34.8/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Niconovum's grants concentrate

Niconovum USA, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Niconovum sits between Nextern Inc. and Nippon Yakin Kogyo Co., Ltd..

Niconovum's three-year grant acceleration

Niconovum USA, Inc. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nextern

10
Nextorch Industri…

10
Nice North America

10
Nicolon

10
Ningbo Qisen Tech…

10
Ningbo Sanhan All…

10
Nippon Gas

10
Nippon Yakin Kogyo

10
Niconovum USA ◀

10

What this shows Niconovum holds 10 patents at rank #26,985, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Niconovum

By rank, the assignees closest to #26,985 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Niconovum's primary technology class.

Niconovum's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Niconovum USA, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	10.0%
2017	3	30.0%
2018	3	30.0%
2019	1	10.0%
2020	1	10.0%
2023	1	10.0%

Which technologies does Niconovum USA, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A24B - Manufacture OR Preparation OF Tobacco FOR Smoking OR CHEWING; TOBACCO; Snuff 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Y10T - Technical Subjects Covered BY Former US Classification 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A24F - Smokers' REQUISITES; Match BOXES; Simulated Smoking Devices 1

A24D - CIGARS; CIGARETTES; Tobacco Smoke FILTERS; Mouthpieces FOR Cigars OR CIGARETTES; Manufacture OF Tobacco Smoke Filters OR Mouthpieces 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#26,974

of 49,997 tracked assignees

Innovation Score

34.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Niconovum USA, Inc.'s patent record in context - here's where to go next.

Niconovum USA, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #26,974 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Niconovum USA, Inc. against Nextern Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.